AIDS denialism and public health practice

AIDS and Behavior

Volumn 14, Issue 2, 2010, Pages 237-247

  Chigwedere, Pride ^a   Essex, M ^a  

^a Harvard AIDS Institute   (United States)

Author keywords

Accountability; Antiretroviral drugs; HIV AIDS denialism; Mortality; South Africa

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; DENIAL; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MORTALITY; NEWBORN; PREGNANCY; PREGNANCY COMPLICATION; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH SERVICE; REVIEW; SOCIAL BEHAVIOR; SOUTH AFRICA; VERTICAL TRANSMISSION; VIROLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTI-HIV AGENTS; DENIAL (PSYCHOLOGY); FEMALE; HIV-1; HUMANS; INFANT, NEWBORN; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PUBLIC HEALTH PRACTICE; SOCIAL RESPONSIBILITY; SOUTH AFRICA;

EID: 77952093217     PISSN: 10907165     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10461-009-9654-7     Document Type: Article

References (141)

1. P Chigwedere GR Seage 3rd S Gruskin TH Lee M Essex 2008 Estimating the lost benefits of antiretroviral drug use in South Africa J Acquir Immune Defic Syndr 49 410 415 19186354
2. N Nattrass 2008 AIDS and the scientific governance of medicine in post-apartheid South Africa African Affairs 107 157 176
3. Duesberg PH, Nicholson JM, Rasnick D, Fiala C, Bauer HH. HIV-AIDS hypothesis out of touch with South African AIDS-a new perspective. Med Hypotheses. 2009; Epub ahead of print (withdrawn).
4. Lenzer J. AIDS "dissident" seeks redemption.. and a cure for cancer. Discover. 2008;29(6):44-50.
5. Duesberg P. HIV is not the cause of AIDS. Science. 1988;241(4865):514, 517. Other of Duesberg's writings available at: < http://www.duesberg.com/ >. Accessed 2009 Nov 17.
6. A Baleta 1999 South Africa's AIDS care thrown into confusion Lancet 354 1711 1:STN:280:DC%2BD3c%2FjtlagsA%3D%3D 10568584
7. J Cohen 2000 South Africa. AIDS researchers decry Mbeki's views on HIV Science 288 590 591 1:CAS:528:DC%2BD3cXivFeru70%3D 10798988
8. R Horton 2000 Mbeki defiant about South African HIV/AIDS strategy Lancet 356 9225 225 1:STN:280:DC%2BD3cvjtVeltg%3D%3D 10963206
9. T Masland P King 2000 Flirting with strange ideas. Mbeki reaches out to a controversial AIDS researcher Newsweek 135 16 36 1:STN:280: DC%2BD3M%2FgtlyitA%3D%3D 10848182
10. Essex M, Mboup S. The etiology of AIDS. In: Essex M, Mboup S, Kanki P, Marlink R, Tlou S, editors. AIDS in Africa. New York: Kluwer Academic/Plenum; 2002. p. 1-10.
11. MS Gottlieb R Schroff HM Schanker, et al. 1981 Pneumocystis carinii pneumonia and mucosal candidiasis in previously healthy homosexual men: evidence of a new acquired cellular immunodeficiency N Engl J Med 305 24 1425 1431 1:STN:280:DyaL38%2Flsl2rtw%3D%3D 6272109
12. H Masur MA Michelis JB Greene, et al. 1981 An outbreak of community-acquired Pneumocystis carinii pneumonia: initial manifestation of cellular immune dysfunction N Engl J Med 305 24 1431 1438 1:STN:280: DyaL38%2Flsl2rtA%3D%3D 6975437
13. FP Siegal C Lopez GS Hammer, et al. 1981 Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions N Engl J Med 305 24 1439 1444 1:STN:280:DyaL38%2Flsl2rtQ%3D%3D 6272110
14. Epidemiological aspects of the current outbreak of Kaposi's sarcoma and opportunistic infections. N Engl J Med. 1982; 306: 248-52.
15. H Masur MA Michelis GP Wormser, et al. 1982 Opportunistic infection in previously healthy women. Initial manifestations of a community-acquired cellular immunodeficiency Ann Intern Med 97 4 533 539 1:STN:280: DyaL3s%2FitVOrug%3D%3D 6982014
16. KC Davis CR Horsburgh Jr U Hasiba AL Schocket CH Kirkpatrick 1983 Acquired immunodeficiency syndrome in a patient with hemophilia Ann Intern Med 98 3 284 286 1:STN:280:DyaL3s7ltV2lsw%3D%3D 6299152
17. MC Poon A Landay EF Prasthofer S Stagno 1983 Acquired immunodeficiency syndrome with Pneumocystis carinii pneumonia and Mycobacterium avium-intracellulare infection in a previously healthy patient with classic hemophilia. Clinical, immunologic, and virologic findings Ann Intern Med 98 3 287 290 1:STN:280:DyaL3s7ltV2lsA%3D%3D 6299153
18. JR Jett JN Kuritsky JA Katzmann HA Homburger 1983 Acquired immunodeficiency syndrome associated with blood-product transfusions Ann Intern Med 99 5 621 624 1:STN:280:DyaL2c%2FltVGktw%3D%3D 6605703
19. JW Curran DN Lawrence H Jaffe, et al. 1984 Acquired immunodeficiency syndrome (AIDS) associated with transfusions N Engl J Med 310 2 69 75 1:STN:280:DyaL2c%2FptlCgtg%3D%3D 6606780
20. A Rubinstein M Sicklick A Gupta, et al. 1983 Acquired immunodeficiency with reversed T4/T8 ratios in infants born to promiscuous and drug-addicted mothers JAMA 249 17 2350 2356 1:STN:280:DyaL3s7msVKmsg%3D%3D 6220166
21. DP Francis JW Curran M Essex 1983 Epidemic acquired immune deficiency syndrome: epidemiologic evidence for a transmissible agent J Natl Cancer Inst 71 1 1 4 1:STN:280:DyaL3s3kt1Crug%3D%3D 6575197
22. DT Durack 1981 Opportunistic infections and Kaposi's sarcoma in homosexual men N Engl J Med 305 24 1465 1467 1:STN:280:DyaL38%2Flsl2qsA%3D%3D 6272112
23. RO Brennan DT Durack 1981 Gay compromise syndrome Lancet 2 8259 1338 1339 1:STN:280:DyaL38%2FnvFOhtQ%3D%3D 6118727
24. LW Kitchen F Barin JL Sullivan, et al. 1984 Aetiology of AIDS-antibodies to human T-cell leukaemia virus (type III) in haemophiliacs Nature 312 5992 367 369 1:STN:280:DyaL2M%2FmtFGmsQ%3D%3D 6095094
25. MG Sarngadharan M Popovic L Bruch J Schüpbach RC Gallo 1984 Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS Science 224 4648 506 508 1:STN:280: DyaL2c7nt1aitg%3D%3D 6324345 (Pubitemid 14134743)
26. F Barre-Sinoussi JC Chermann F Rey, et al. 1983 Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS) Science 220 4599 868 871 1:STN:280:DyaL3s7pslelug%3D%3D 6189183
27. RC Gallo PS Sarin EP Gelmann, et al. 1983 Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS) Science 220 4599 865 867 1:STN:280:DyaL3s7psleltQ%3D%3D 6601823
28. Aschengrau A, Seage GR. Essentials of epidemiology in public health. 2nd ed. Sudbury, MA: Jones & Bartlett; 2008. p. 383-410.
29. Knight DC, Schrotter G. Robert Koch: father of bacteriology. New York: Franklin Watts; 1961.
30. Z Ambrose VN KewalRamani PD Bieniasz T Hatziioannou 2007 HIV/AIDS: in search of an animal model Trends Biotechnol 25 8 333 337 1:CAS:528: DC%2BD2sXns1yltL4%3D 17574286
31. J Cohen 1994 Fulfilling Koch's postulates Science 266 1647
32. SJ O'Brien JJ Goedert 1996 HIV causes AIDS: Koch's postulates fulfilled Curr Opin Immunol 8 5 613 618 8902385
33. AB Hill 1965 The environment and disease: association or causation? Proc R Soc Med. 58 295 300 1:STN:280:DyaF2M%2FovVCmsw%3D%3D 14283879
34. MT Schechter KJ Craib KA Gelmon JS Montaner TN Le MV O'Shaughnessy 1993 HIV-1 and the aetiology of AIDS Lancet 341 8846 658 659 1:STN:280: DyaK3s7ps1artA%3D%3D 8095571
35. SC Darby DW Ewart PL Giangrande PJ Dolin RJ Spooner CR Rizza 1995 Mortality before and after HIV infection in the complete UK population of haemophiliacs. UK Haemophilia Centre Directors' Organisation Nature 377 6544 79 82 1:CAS:528:DyaK2MXnvFektbo%3D 7659168
36. RJ Biggar 1990 AIDS incubation in 1891 HIV seroconverters from different exposure groups. International Registry of Seroconverters AIDS 4 11 1059 1066 1:STN:280:DyaK3M7ivVKmtA%3D%3D 2282177
37. M Prins PJ Veugelers 1997 Comparison of progression and non-progression in injecting drug users and homosexual men with documented dates of HIV-1 seroconversion. European Seroconverter Study and the Tricontinental Seroconverter Study AIDS 11 5 621 631 1:STN:280:DyaK2s3mt1Klsg%3D%3D 9108944
38. EA Engels PS Rosenberg TR O'Brien JJ Goedert 1999 Plasma HIV viral load in patients with hemophilia and late-stage HIV disease: a measure of current immune suppression. Multicenter Hemophilia Cohort Study Ann Intern Med 131 4 256 264 1:STN:280:DyaK1MzmvFChsA%3D%3D 10454946
39. JW Mellors CR Rinaldo Jr P Gupta RM White JA Todd LA Kingsley 1996 Prognosis in HIV-1 infection predicted by the quantity of virus in plasma Science 272 5265 1167 1170 1:CAS:528:DyaK28XjtF2nsrg%3D 8638160
40. SM Hammer KE Squires MD Hughes, et al. 1997 A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less N Engl J Med 337 725 733 1:CAS:528:DyaK2sXmt1yit7o%3D 9287227
41. DA Katzenstein SM Hammer MD Hughes, et al. 1996 The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team N Engl J Med 335 15 1091 1098 1:CAS:528:DyaK28XmsValtrc%3D 8813039
42. WA O'Brien PM Hartigan D Martin, et al. 1996 Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS N Engl J Med 334 7 426 431 8552144
43. Levy JA. HIV and the pathogenesis of AIDS. 3rd ed. Washington: ASM Press; 2007.
44. Knipe DM, Howley PM, editors. Fields' virology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2007.
45. J Cohen 1994 Duesberg and critics agree: hemophilia is the best test Science 266 1645 1646 1:CAS:528:DyaK2MXis12rsLw%3D 7992044
46. R Horton 1995 Will Duesberg now concede defeat? Lancet 346 8976 656 1:STN:280:DyaK2MzoslOltQ%3D%3D 7658817
47. PH Duesberg 1995 Is HIV the cause of AIDS? Lancet 346 8986 1371 1372 1:STN:280:DyaK28%2FmsV2luw%3D%3D 7475805
48. W Blattner RC Gallo HM Temin 1988 HIV causes AIDS Science 241 4865 515 516 1:STN:280:DyaL1c3ptVKlsA%3D%3D 3399881
49. C Pachl JA Todd DG Kern, et al. 1995 Rapid and precise quantification of HIV-1 RNA in plasma using a branched DNA signal amplification assay J Acquir Immune Defic Syndr Hum Retrovirol 8 5 446 454 1:CAS:528:DyaK2MXls1Cjsbk%3D 7697440
50. DR Henrard JF Phillips LR Muenz, et al. 1995 Natural history of HIV-1 cell-free viremia JAMA 274 7 554 558 1:STN:280:DyaK2Mzls1entA%3D%3D 7629984
51. JM Coffin 1995 HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy Science 267 5197 483 489 1:CAS:528:DyaK2MXjsFShu7w%3D 7824947
52. DD Ho AU Neumann AS Perelson W Chen JM Leonard M Markowitz 1995 Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection Nature 373 6510 123 126 1:CAS:528:DyaK2MXjtFSrt7o%3D 7816094
53. AC Collier RW Coombs DA Schoenfeld, et al. 1996 Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zalcitabine. AIDS Clinical Trials Group N Engl J Med 334 16 1011 1017 1:CAS:528: DyaK28XivFait74%3D 8598838
54. Essex M, Mboup S, Kanki P, Marlink R, Tlou S, editors. AIDS in Africa. New York: Kluwer Academic/Plenum; 2002.
55. Lu Y, Essex M, editors. AIDS in Asia. New York: Kluwer Academic/Plenum; 2004.
56. Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 10.
57. Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 169.
58. PH Duesberg D Rasnick 1998 The AIDS dilemma: drug diseases blamed on a passenger virus Genetica 104 85 132 1:STN:280:DyaK1M3jslamtg%3D%3D 10220905
59. Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 255-97.
60. PH Duesberg 1989 Human immunodeficiency virus and acquired immunodeficiency syndrome: correlation but not causation Proc Natl Acad Sci USA 86 755 764 1:STN:280:DyaL1M7ivVymtQ%3D%3D 2644642
61. PH Duesberg 1991 AIDS epidemiology: inconsistencies with human immunodeficiency virus and with infectious disease Proc Natl Acad Sci USA 88 1575 1579 1:STN:280:DyaK3M7kt1aitA%3D%3D 1996359
62. Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 175.
63. PH Duesberg 1996 Duesberg defends challenges to the existence of HIV Continuum 4 2 8 9
64. PH Duesberg 1992 The role of drugs in the origin of AIDS Biomed Pharmacother 46 3 15 1:CAS:528:DyaK38Xks1ajs7o%3D 1421032
65. PH Duesberg 1995 Foreign-protein-mediated immunodeficiency in hemophiliacs with and without HIV Genetica 95 51 70 1:STN:280: DyaK2M3mt12itw%3D%3D 7744263
66. JP Allain 2003 Transfusion risks of yesterday and of today Transfus Clin Biol 10 1 1 5 12668180
67. P Duesberg C Koehnlein D Rasnick 2003 The chemical bases of the various AIDS epidemics: recreational drugs, anti-viral chemotherapy and malnutrition J Biosci 28 4 383 412 12799487
68. Kalichman SC. Denying AIDS: conspiracy theories, pseudoscience, and human tragedy. New York and London: Copernicus/Springer; 2009. p. 44.
69. Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 184-5.
70. Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 187.
71. Duesberg PH. Inventing the AIDS virus. Washington: Regnery; 1997. p. 419.
72. UNAIDS. Report on the global HIV/AIDS epidemic. Geneva: UNAIDS; 2008.
73. HX Barnhart MB Caldwell P Thomas, et al. 1996 Natural history of human immunodeficiency virus disease in perinatally infected children: an analysis from the Pediatric Spectrum of Disease Project Pediatrics 97 5 710 716 1:STN:280:DyaK283gs1ejtQ%3D%3D 8628612
74. European Collaborative Study 1991 Children born to women with HIV-1 infection: natural history and risk of transmission Lancet 337 8736 253 260
75. ML Newell MC Borja C Peckham 2003 European Collaborative Study. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe Pediatrics 111 1 e52 e60 12509595
76. UNAIDS. Report on the global HIV/AIDS epidemic. Geneva: UNAIDS; 2000.
77. PH Duesberg 1992 AIDS acquired by drug consumption and other noncontagious risk factors Pharmac Ther 55 201 277 1:STN:280: DyaK3s7ltVSmsA%3D%3D
78. WM Msisha SH Kapiga F Earls SV Subramanian 2008 Socioeconomic status and HIV seroprevalence in Tanzania: a counterintuitive relationship Int J Epidemiol 37 6 1297 1303 18820319
79. P Piot R Greener S Russell 2007 Squaring the circle: AIDS, poverty, and human development PLoS Med 4 10 1571 1575 17958469
80. K Begtrup M Melbye RJ Biggar JJ Goedert K Knudsen PK Andersen 1997 Progression to acquired immunodeficiency syndrome is influenced by CD4 T-lymphocyte count and time since seroconversion Am J Epidemiol 145 7 629 635 1:STN:280:DyaK2s3lt1OhsA%3D%3D 9098180
81. SH Vermund DR Hoover K Chen 1993 CD4+ counts in seronegative homosexual men. The Multicenter AIDS Cohort Study N Engl J Med 328 6 442 1:STN:280:DyaK3s7jtlansw%3D%3D 8093639
82. DC Des Jarlais SR Friedman M Marmor, et al. 1993 CD4 lymphocytopenia among injecting drug users in New York City J Acquir Immune Defic Syndr 6 7 820 822 1:STN:280:DyaK3s3os1ykuw%3D%3D 8099613 (Pubitemid 23183355)
83. E Donegan M Stuart JC Niland, et al. 1990 Infection with human immunodeficiency virus type 1 (HIV-1) among recipients of antibody-positive blood donations Ann Intern Med 113 10 733 739 1:STN:280:DyaK3M%2Flt1Olsw%3D%3D 2240875
84. SM Hughes B Amadi M Mwiya, et al. 2009 CD4 counts decline despite nutritional recovery in HIV-infected Zambian children with severe malnutrition Pediatrics 123 2 e347 e351 19124582
85. O Aina J Dadik M Charurat, et al. 2005 Reference values of CD4 T lymphocytes in human immunodeficiency virus-negative adult Nigerians Clin Diagn Lab Immunol 12 4 525 530 1:CAS:528:DC%2BD2MXhtVejsrnM 15817761
86. M Maclure 1998 Inventing the AIDS virus hypothesis: an illustration of scientific vs unscientific induction Epidemiology 9 4 467 473 1:STN:280:DyaK1czhtFOhsg%3D%3D 9647914
87. J Cohen 1994 The Duesberg phenomenon Science 266 1642 1644 1:CAS:528:DyaK2MXis12rsL8%3D 7992043
88. Kalichman SC. Denying AIDS: conspiracy theories, pseudoscience, and human tragedy. New York and London: Copernicus/Springer; 2009. p. 9.
89. HJ Schünemann A Fretheim AD Oxman 2006 Improving the use of research evidence in guideline development: 9. Grading evidence and recommendations Health Res Policy Syst 4 21 17147810
90. Chin R, Lee BY. Principles and practice of clinical trial medicine. London: Academic Press; 2008.
91. Light RJ, Pillemer DB. Summing up: the science of reviewing research. Cambridge: Harvard University Press; 1984.
92. Egger M, Davey Smith G, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ; 2001.
93. D Moher DJ Cook S Eastwood I Olkin D Rennie DF Stroup 1999 Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses Lancet 354 9193 1896 1900 1:STN:280:DC%2BD3c%2FkvFCgtQ%3D%3D 10584742
94. P Chigwedere GR Seage TH Lee M Essex 2008 Efficacy of antiretroviral drugs in reducing mother-to-child transmission of HIV in Africa: a meta-analysis of published clinical trials AIDS Res Hum Retroviruses 24 6 827 837 1:CAS:528:DC%2BD1cXns1Onurs%3D 18544018
95. D Atkins D Best PA Briss, et al. 2004 GRADE Working Group. Grading quality of evidence and strength of recommendations BMJ 328 7454 1490 15205295
96. AR Jadad RA Moore D Carroll, et al. 1996 Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1 1 12 1:STN:280:DyaK28zgvVCmug%3D%3D 8721797
97. Institute of Medicine. Adverse events associated with childhood vaccines: evidence bearing on causality. Washington: National Academy Press; 1993.
98. Stoto MA. Research synthesis for public health policy: experience of the Institute of Medicine. In: Stangl D, Berry D, editors. Meta-analysis in medicine and health policy. New York: Marcel Dekker; 2000.
99. J Volmink NL Siegfried L van der Merwe P Brocklehurst 2007 Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection Cochrane Database Syst Rev 1 CD003510 17253490
100. N Suksomboon N Poolsup S Ket-Aim 2007 Systematic review of the efficacy of antiretroviral therapies for reducing the risk of mother-to-child transmission of HIV infection J Clin Pharm Ther 32 293 311 1:CAS:528: DC%2BD2sXmvVWmsLs%3D 17489882
101. JA Bartlett SL Benoit VA Johnson, et al. 1996 Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party Ann Intern Med 125 3 161 172 1:CAS:528:DyaK28XltVansbg%3D 8686973
102. SA Nachman K Stanley R Yogev, et al. 2000 Nucleoside analogs plus ritonavir in stable antiretroviral therapy-experienced HIV-infected children: a randomized controlled trial. Pediatric AIDS Clinical Trials Group 338 Study Team JAMA 283 4 492 498 1:CAS:528:DC%2BD3cXns1yqsg%3D%3D 10659875
103. J Darbyshire M Foulkes R Peto, et al. 2000 Zidovudine (AZT) versus AZT plus didanosine (ddI) versus AZT plus zalcitabine (ddC) in HIV infected adults Cochrane Database Syst Rev 3 CD002038 10908523
104. R Jordan L Gold C Cummins C Hyde 2002 Systematic review and meta-analysis of evidence for increasing numbers of drugs in antiretroviral combination therapy BMJ 324 7340 757 1:CAS:528:DC%2BD38XjsFWhs7g%3D 11923157
105. G Rutherford P Sangani GE Kennedy 2003 Three- or four- versus two-drug antiretroviral maintenance regimens for HIV infection Cochrane Database Syst Rev 3 CD002037
106. N Siegfried PJU van Deventer FA Mahomed G Rutherford 2006 Stavudine, lamivudine and nevirapine combination therapy for treatment of HIV infection and AIDS in adults Cochrane Database Syst Rev 2 CD004535 16625606
107. E Humphreys LB Hernandez G Rutherford 2007 Antiretroviral regimens for patients with HIV who fail first-line antiretroviral therapy Cochrane Database Syst Rev 4 CD006517 17943914
108. M Shey EJ Kongnyuy J Shang CS Wiysonge 2009 A combination drug of abacavir-lamivudine-zidovudine (Trizivir®) for treating HIV infection and AIDS Cochrane Database Syst Rev 3 CD005481 19588374
109. G Djomand T Roels T Ellerbrock, et al. 2003 Virologic and immunologic outcomes and programmatic challenges of an antiretroviral treatment pilot project in Abidjan, Cote d'Ivoire AIDS 17 Suppl 3 S5 S15 14565604
110. D Coetzee K Hildebrand A Boulle, et al. 2004 Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa AIDS 18 6 887 895 15060436
111. CW Wester S Kim H Bussmann, et al. 2005 Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana J Acquir Immune Defic Syndr 40 3 336 343 16249709
112. JF Etard I Ndiaye M Thierry-Mieg, et al. 2006 Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study AIDS 20 8 1181 1189 16691070
113. JS Stringer I Zulu J Levy, et al. 2006 Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes JAMA 296 7 782 793 1:CAS:528:DC%2BD28XosVCltLw%3D 16905784
114. LC Ivers D Kendrick K Doucette 2005 Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature Clin Infect Dis 41 2 217 224 1:CAS:528:DC%2BD2MXmvVyltLw%3D 15983918
115. R Hammond TC Harry 2008 Efficacy of antiretroviral therapy in Africa: effect on immunological and virological outcome measures: a meta-analysis Int J STD AIDS 19 5 291 296 18482957
116. P Braitstein MW Brinkhof F Dabis, et al. 2006 Antiretroviral therapy in lower income countries (ART-LINC) collaboration; ART cohort collaboration (ART-CC) groups. Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries Lancet 367 9513 817 824 16530575
117. Preston S, Heuveline P, Guillot M. Demography: measuring and modeling population processes. Oxford: Wiley-Blackwell; 2000. p. 1-20.
118. Statistics South Africa. Mortality and causes of death in South Africa, 2006: findings from death notification. South Africa: Statistics South Africa; 2008.
119. Stanecki KA, Walker N. Current estimates and projections for the epidemic. In: Essex M, Mboup S, Kanki P, Marlink R, Tlou S, editors. AIDS in Africa. New York: Kluwer Academic/Plenum; 2002. p. 281-96.
120. Dorrington R, Bourne D, Bradshaw D, Laubscher R, Timæus I. The impact of HIV/AIDS on adult mortality in South Africa. Burden of Disease Research Unit, Medical Research Council (SA); 2001:10. Available at: < http://www.mrc.ac.za/bod/complete.pdf >. Accessed 2009 Aug 9.
121. UNAIDS Reference Group on Estimates, Modelling and Projections 2002 Improved methods and assumptions for estimation of the HIV/AIDS epidemic and its impact: recommendations of the UNAIDS Reference Group on Estimates, Modelling and Projections AIDS 16 9 W1 W14
122. N Walker KA Stanecki T Brown, et al. 2003 Methods and procedures for estimating HIV/AIDS and its impact: the UNAIDS/WHO estimates for the end of 2001 AIDS 17 15 2215 2225 14523279
123. J Stover P Johnson B Zaba M Zwahlen F Dabis RE Ekpini 2008 The spectrum projection package: improvements in estimating mortality, ART needs, PMTCT impact and uncertainty bounds Sex Transm Infect 84 Suppl 1 i24 i30 18647862
124. J Stover PD Ghys N Walker 2004 Testing the accuracy of demographic estimates in countries with generalized epidemics AIDS 18 Suppl 2 S67 S73 15319745
125. NC Grassly M Morgan N Walker, et al. 2004 Uncertainty in estimates of HIV/AIDS: the estimation and application of plausibility bounds Sex Transm Infect 80 Suppl 1 i31 i38 15249697
126. N Walker NC Grassly GP Garnett KA Stanecki PD Ghys 2004 Estimating the global burden of HIV/AIDS: what do we really know about the HIV pandemic? Lancet 363 9427 2180 2185 15220043
127. E Gouws V Mishra TB Fowler 2008 Comparison of adult HIV prevalence from national population-based surveys and antenatal clinic surveillance in countries with generalised epidemics: implications for calibrating surveillance data Sex Transm Infect 84 Suppl 1 i17 i23 18647861
128. Actuarial Society of South Africa. ASSA 2003 AIDS and demographic model. Cape Town: Actuarial Society of South Africa; 2005.
129. JT Boerma AJ Nunn JA Whitworth 1998 Mortality impact of the AIDS epidemic: evidence from community studies in less developed countries AIDS 12 Suppl 1 S3 S14 9677185
130. J Blacker 2004 The impact of AIDS on adult mortality: evidence from national and regional statistics AIDS 18 Suppl 2 S19 S26 15319740
131. J Stover P Way 1998 Projecting the impact of AIDS on mortality AIDS 12 Suppl 1 S29 S39 9677187
132. The Durban Declaration. Nature 2000;406:15-6.
133. R Horton 2000 African AIDS beyond Mbeki: tripping into anarchy Lancet 356 9241 1541 1542 1:STN:280:DC%2BD3M%2Fks1OjtQ%3D%3D 11075765
134. Kalichman SC. Denying AIDS: conspiracy theories, pseudoscience, and human tragedy. New York and London: Copernicus/Springer; 2009. p. 8-13.
135. Cameron E. Witness to AIDS. London: I. B. Tauris; 2005.
136. JP Moore 2009 The dangers of denying HIV Nature 459 168 1:CAS:528:DC%2BD1MXlvFShtr0%3D
137. N Geffen 2009 Justice after AIDS denialism: should there be prosecutions and compensation? J Acquir Immune Defic Syndr 51 4 454 455 19623695
138. Wainberg M. In: Scovill R. The other side of AIDS (film); 2004. Available at: http://www.theothersideofaids.com/free-to-question.html. Accessed 2009 Nov 27.
139. Muga W. When public negligence can become criminal. African Business 2009 May.
140. Moore JP, Bergman J, Wainberg MA. The AIDS denialists are still around. IAS Newsl. 2007:4-5.
141. Chigwedere PM. Antiretroviral drug use in South Africa: from science to practice and malpractice (Dissertation). Boston: Harvard School of Public Health; 2008.